These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15256490)

  • 1. Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.
    Strle K; Broussard SR; McCusker RH; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2004 Oct; 145(10):4592-602. PubMed ID: 15256490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
    Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts.
    Broussard SR; McCusker RH; Novakofski JE; Strle K; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2003 Jul; 144(7):2988-96. PubMed ID: 12810554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts.
    Broussard SR; McCusker RH; Novakofski JE; Strle K; Shen WH; Johnson RW; Dantzer R; Kelley KW
    J Immunol; 2004 Jun; 172(12):7713-20. PubMed ID: 15187154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
    Frost RA; Nystrom GJ; Lang CH
    Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis.
    Frost RA; Lang CH; Gelato MC
    Endocrinology; 1997 Oct; 138(10):4153-9. PubMed ID: 9322924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent.
    MacRae VE; Burdon T; Ahmed SF; Farquharson C
    J Endocrinol; 2006 Nov; 191(2):369-77. PubMed ID: 17088406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.
    Shen WH; Zhou JH; Broussard SR; Freund GG; Dantzer R; Kelley KW
    Cancer Res; 2002 Aug; 62(16):4746-56. PubMed ID: 12183434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
    Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
    Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts.
    Strle K; McCusker RH; Tran L; King A; Johnson RW; Freund GG; Dantzer R; Kelley KW
    J Neuroimmunol; 2007 Aug; 188(1-2):48-55. PubMed ID: 17572510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression.
    Ge X; Yu J; Jiang H
    J Anim Sci; 2012 Apr; 90(4):1126-33. PubMed ID: 22100600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression.
    Florini JR; Ewton DZ; Roof SL
    Mol Endocrinol; 1991 May; 5(5):718-24. PubMed ID: 1649394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to TNF-alpha but not IL-1beta impairs insulin-dependent phosphorylation of protein kinase B and p70S6k in mouse C2C12 myogenic cells.
    Grzelkowska-Kowalczyk K; Wieteska-Skrzeczyńska W
    Pol J Vet Sci; 2006; 9(1):1-10. PubMed ID: 16573269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium perfringens α-toxin inhibits myogenic differentiation of C2C12 myoblasts.
    Takehara M; Kobayashi K; Nagahama M
    Anaerobe; 2020 Oct; 65():102265. PubMed ID: 32860931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation.
    Mebarek S; Komati H; Naro F; Zeiller C; Alvisi M; Lagarde M; Prigent AF; Némoz G
    J Cell Sci; 2007 Feb; 120(Pt 3):407-16. PubMed ID: 17213336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis.
    Santana P; Llanes L; Hernandez I; Gonzalez-Robayna I; Tabraue C; Gonzalez-Reyes J; Quintana J; Estevez F; Ruiz de Galarreta CM; Fanjul LF
    Endocrinology; 1996 Jun; 137(6):2480-9. PubMed ID: 8641202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.
    Mori K; Stone S; Braverman LE; DeVito WJ
    Endocrinology; 1996 Nov; 137(11):4994-9. PubMed ID: 8895373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3.
    Al-Shanti N; Stewart CE
    J Cell Biochem; 2012 Mar; 113(3):923-33. PubMed ID: 22033984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.